Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Carla M. Van Bennekom"'
Autor:
Nedghie Adrien, Nina L. Schrager, Carla M. Van Bennekom, Allen A. Mitchell, Samantha E. Parker, Martha M. Werler
Publikováno v:
Paediatr Perinat Epidemiol
BACKGROUND: Although nausea and vomiting of pregnancy (NVP) is common, the secular and demographic trends of NVP and its treatments are not well-studied. OBJECTIVES: To describe the prevalence and patterns of first-trimester NVP and selected treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::969fe96ef6551f811b42952cfb7e5dc5
https://doi.org/10.1111/ppe.12705
https://doi.org/10.1111/ppe.12705
Autor:
Drucilla J. Roberts, Dominique Heinke, Wendy N. Nembhard, Janet W. Rich-Edwards, Sonia Hernandez-Diaz, Ruth C. Fretts, Mahsa M. Yazdy, Suzan L. Carmichael, Paige L. Williams, Allen A. Mitchell, Eirini Nestoridi, C. Wes Duke, Angela E. Lin, Carla M. Van Bennekom
Publikováno v:
Obstetrics & Gynecology. 135:133-140
OBJECTIVE: To estimate the risk of stillbirth (fetal death at 20 weeks of gestation or more) associated with specific birth defects. METHODS: We identified a population-based retrospective cohort of neonates and fetuses with selected major birth defe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce351b3408d9f0e78874959dce15ef69
https://doi.org/10.1097/aog.0000000000003614
https://doi.org/10.1097/aog.0000000000003614
Autor:
Meredith M Howley, Carla M. Van Bennekom, Suzan L. Carmichael, Eleni A. Papadopoulos, Alissa R. Van Zutphen, JeanPierre W. Munsie, Marilyn L. Browne, Michele L Herdt
Publikováno v:
J Allergy Clin Immunol Pract
Background Evidence regarding associations between maternal asthma medication use and birth defects is mixed. Objective Estimate associations between asthma medciation use and 52 birth defects using National Birth Defects Prevention Study data from 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68db4a4d1024a0d3429854043f7ed915
https://pubmed.ncbi.nlm.nih.gov/32745701
https://pubmed.ncbi.nlm.nih.gov/32745701
Publikováno v:
Pharmacoepidemiology and Drug Safety. 28:269-273
To assess agreement between maternal recall and medical records for gestational age (GA) at birth as derived from dating information and birthweight.In the case-control Slone Birth Defects Study, within 6 months of delivery, trained nurses conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69d746fa23909b02a2cda20dc193b5dd
https://doi.org/10.1002/pds.4699
https://doi.org/10.1002/pds.4699
Ondansetron for Treatment of Nausea and Vomiting of Pregnancy and the Risk of Specific Birth Defects
Publikováno v:
Obstetrics & Gynecology. 132:385-394
To use data from two large studies of birth defects to describe time trends in ondansetron use for the treatment of first-trimester nausea and vomiting of pregnancy and to investigate associations, either previously reported or undescribed, between f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d3d19a5fc21f8483e32d07ab4848f22
https://doi.org/10.1097/aog.0000000000002679
https://doi.org/10.1097/aog.0000000000002679
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report
Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is recommended during the third trimester of each pregnancy to provide protection to newborns, who are at risk for pertussis-related morbidity and mortality (1). As par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b1567694d33881eb3816a1432de4d0a
https://doi.org/10.15585/mmwr.mm6641a3
https://doi.org/10.15585/mmwr.mm6641a3
Publikováno v:
Birth defects researchREFERENCES. 112(5)
Background The tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is recommended during pregnancy to protect newborns against pertussis infection in the months prior to their primary pertussis vaccination. Although rese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b0f774d40182dd9d85f7ef2d95321d
https://pubmed.ncbi.nlm.nih.gov/31903700
https://pubmed.ncbi.nlm.nih.gov/31903700
Publikováno v:
Birth defects researchREFERENCES. 111(19)
Background Influenza during pregnancy contributes to maternal morbidity and mortality. Neuraminidase inhibitors, including oseltamivir, are recommended for treating women with influenza during pregnancy. Methods Data from the Slone Birth Defects Stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb7e656ad8cba742f014e02ce1092258
https://pubmed.ncbi.nlm.nih.gov/31397115
https://pubmed.ncbi.nlm.nih.gov/31397115
Autor:
Stephen J. Kerr, Michael Schatz, Allen A. Mitchell, Kenneth L. Jones, Carla M. Van Bennekom, Christina D. Chambers, Carol Louik
Publikováno v:
Vaccine. 34:4450-4459
Pregnant women have higher risks of influenza complications, but vaccine coverage is incomplete. Because concern about fetal harm limits uptake, we investigated risks for preterm delivery (PTD) and specific birth defects following vaccination in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9dd741da9b4462ff52869f69033e364
https://doi.org/10.1016/j.vaccine.2016.06.078
https://doi.org/10.1016/j.vaccine.2016.06.078
Autor:
Tatsuya Takagi, Masao Nasu, Chizuko Hattori, Steffen Amann, Yuko Shirakuni, Tsugumichi Sato, Carla M. Van Bennekom
Publikováno v:
YAKUGAKU ZASSHI. 135:1161-1168
Thalidomide was approved for the treatment of multiple myeloma in Japan under a risk management program, named TERMS, in 2008. Since then, we have been conducting a survey of the stakeholders to assess the effectiveness of TERMS. These surveys showed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::948e43b80fd11b63603c3961a0d30590
https://doi.org/10.1248/yakushi.15-00118
https://doi.org/10.1248/yakushi.15-00118